Wednesday, July 8, 2026

Intelligence · Clinical Development

Pipeline search results

Programs matching “asthma” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.

Matching programs 226
Total indexed 20,548
Sponsors 1,769

Quick answer

Showing 226 pipeline programs matching "asthma" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.

Refine search

226 results for “asthma” Back to intelligence hub

Search results

Page 4 of 10
  1. TEV-56248

    Teva Generics B.V

    Asthma

    phase 3 small molecule active

    1 trial
  2. Test Product

    Amneal Pharma Europe Ltd

    Asthma

    phase 3 small molecule active

    2 trials
  3. Tezepelumab

    AstraZeneca

    Asthma

    phase 3 mab active

    2 trials
  4. Tezspire 210 mg solution for injection in pre-filled syringe

    AstraZeneca AB

    Severe Asthma

    phase 3 small molecule active

    1 trial
  5. albuterol (Armstrong Albuterol HFA)

    Amphastar France Pharmaceuticals

    Asthma

    phase 3 small molecule terminated

    1 trial
  6. albuterol HFA (Armstrong's)

    Amphastar France Pharmaceuticals

    Asthma

    phase 3 small molecule terminated

    1 trial
  7. beclomethasone dipropionate (QVAR)

    Teva Pharma GmbH

    Asthma

    phase 3 small molecule completed

    1 trial
  8. budesonide/formoterol 'as needed' + budesonide placebo bid

    AstraZeneca

    Asthma

    phase 3 small molecule completed

    1 trial
  9. ciclesonide

    Takeda

    Asthma

    phase 3 small molecule completed

    2 trials
  10. epinephrine inhalation aerosol

    Amphastar France Pharmaceuticals

    Asthma

    phase 3 small molecule completed

    2 trials
  11. formoterol

    Pacira Ireland Limited

    Asthma

    phase 3 other completed

    1 trial
  12. lebrikizumab

    Hoffmann-La Roche

    Asthma

    phase 3 small molecule completed

    2 trials
  13. reslizumab

    Teva Pharma GmbH

    Eosinophils, Asthma

    phase 3 small molecule terminated

    1 trial
  14. tiotropium 5mcg/day

    Boehringer Ingelheim

    Asthma

    phase 3 small molecule completed

    1 trial
  15. tiotropium high dose

    Boehringer Ingelheim

    Asthma

    phase 3 small molecule completed

    1 trial
  16. 610 100mg

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Asthma

    phase 2 small molecule active

    1 trial
  17. A006

    Amphastar France Pharmaceuticals

    Asthma

    phase 2 small molecule completed

    1 trial
  18. A006 DPI

    Amphastar France Pharmaceuticals

    Asthma

    phase 2 small molecule completed

    2 trials
  19. ACT18301

    Sanofi-aventis Healthcare Pty Ltd

    Asthma

    phase 2 small molecule active

    1 trial
  20. ADX-629

    Aldeyra Therapeutics

    Atopic Asthma

    phase 2 small molecule completed

    1 trial
  21. API-E004-CL-A

    Amphastar France Pharmaceuticals

    Asthma

    phase 2 small molecule terminated

    1 trial
  22. API-E004-CL-B4

    Amphastar France Pharmaceuticals

    Asthma

    phase 2 small molecule terminated

    1 trial
  23. ARO-MUC5AC

    Arrowhead Pharmaceuticals Ireland Limited

    Asthma

    phase 2 small molecule terminated

    1 trial
  24. ARO-RAGE

    Arrowhead Pharmaceuticals Ireland Limited

    Asthma

    phase 2 small molecule active

    2 trials

Frequently asked questions

What is the Clinical Development Intelligence Platform?

It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.

How does this compare to Evaluate Pharma or Citeline?

Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.

Where does pipeline data come from?

Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.

Can I follow a company or program for updates?

Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.